We are live on
!
Find out more
TC
Truvestments Capital Portfolio holdings
AUM
$554M
1-Year Est. Return
32.49%
This Fund
S&P 500
This Quarter
Est. Return
+7.39%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$9.15M
(-6%)
Cap. Flow
-$18.1M
Cap. Flow
% of AUM
-12.5%
Top 10 Holdings %
Top 10 Hldgs %
26.79%
Holding
704
New
1
Increased
73
Reduced
49
Closed
564
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$269K |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$197K |
| 3 |
Altria Group
MO
|
+$144K |
| 4 |
MPT
Medical Properties Trust
MPT
|
+$127K |
| 5 |
ExxonMobil
XOM
|
+$117K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$582K |
| 2 |
Marathon Petroleum
MPC
|
+$200K |
| 3 |
AerCap
AER
|
+$196K |
| 4 |
XPO
XPO
|
+$195K |
| 5 |
Campbell Soup
CPB
|
+$186K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.31% |
| 2 | Healthcare | 10.05% |
| 3 | Consumer Staples | 8.95% |
| 4 | Communication Services | 7.78% |
| 5 | Industrials | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ares Capital
ARCC
$14.4B
| $617K | 0.43% |
33,097
+4,109
| +14% | +$76.3K |
|
77
Toronto Dominion Bank
TD
$200B
| $606K | 0.42% |
10,788
-608
| -5% | -$34.5K |
|
78
Salesforce
CRM
$158B
| $599K | 0.41% |
3,685
+227
| +7% | +$35.6K |
|
79
Warner Bros
WBD
$67.1B
| $590K | 0.41% |
18,020
+246
| +1% | +$7.41K |
|
80
CSX Corp
CSX
$93.1B
| $575K | 0.4% |
23,820
-2,421
| -9% | -$57.3K |
|
|
BPYU
81
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $564K | 0.39% |
30,599
+4,025
| +15% | +$76.2K |
|
82
Alphabet (Google) Class A
GOOGL
$4.33T
| $557K | 0.39% |
8,320
+40
| +0.5% | +$2.58K |
|
83
Energy Transfer Partners
ET
$69.3B
| $547K | 0.38% |
42,598
-1,665
| -4% | -$20.5K |
|
|
84
Bristol-Myers Squibb
BMY
$132B
| $542K | 0.38% |
8,444
+4,695
| +125% | +$269K |
|
85
Simon Property Group
SPG
$72.3B
| $539K | 0.37% |
3,619
+495
| +16% | +$74.2K |
|
86
Stryker
SYK
$130B
| $509K | 0.35% |
2,425
| – | – |
|
87
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $498K | 0.34% |
1,547
-68
| -4% | -$20.9K |
|
88
Woodward
WWD
$21.4B
| $474K | 0.33% |
4,000
| – | – |
|
89
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.83B
| $468K | 0.32% |
3,148
+155
| +5% | +$21.3K |
|
90
Walmart Inc
WMT
$890B
| $468K | 0.32% |
11,802
-150
| -1% | -$5.96K |
|
91
iShares Core S&P Small-Cap ETF
IJR
$112B
| $446K | 0.31% |
5,322
+5
| +0.1% | +$402 |
|
92
Chevron
CVX
$366B
| $443K | 0.31% |
3,674
+197
| +6% | +$23.2K |
|
93
Home Depot
HD
$355B
| $440K | 0.3% |
2,016
+203
| +11% | +$46K |
|
94
iShares MSCI EAFE ETF
EFA
$80.2B
| $414K | 0.29% |
5,967
| – | – |
|
95
Micron Technology
MU
$991B
| $414K | 0.29% |
7,701
+57
| +0.7% | +$2.72K |
|
96
Norwegian Cruise Line
NCLH
$8.84B
| $390K | 0.27% |
6,671
-1,549
| -19% | -$81.8K |
|
|
MPT
97
Medical Properties Trust
MPT
$2.81B
| $386K | 0.27% |
18,306
+6,271
| +52% | +$127K |
|
98
Union Pacific
UNP
$174B
| $371K | 0.26% |
2,053
| – | – |
|
99
Starbucks
SBUX
$120B
| $364K | 0.25% |
4,143
-134
| -3% | -$11.4K |
|
100
Philip Morris
PM
$295B
| $362K | 0.25% |
4,255
+35
| +0.8% | +$2.88K |
|
Similar funds
CA
SVCM
CAM
TC
BT
QL
IQI
TCM
Truvestments Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Truvestments Capital held 704 positions worth $144M, down 6% from $154M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Truvestments Capital withdrew a net $18.1M in Q4 2019, closing 564 positions and reducing 49 holdings. Its most notable exit was Celgene Corp, an estimated $582K position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Truvestments Capital opened a new position in Vanguard FTSE Developed Markets ETF worth $204K.
- Truvestments Capital's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 4,627 shares worth $204K.
- Truvestments Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $269K increase.
- Truvestments Capital's biggest Q4 2019 reduction was Apple, cutting an estimated $151K.
- Truvestments Capital fully exited Celgene Corp in Q4 2019, selling an estimated $582K.
- Truvestments Capital's ten largest holdings make up 27% of its $144M portfolio in Q4 2019.
- Truvestments Capital opened 1 new position and closed 564 in Q4 2019.
- Truvestments Capital's portfolio value fell 6% quarter-over-quarter to $144M.
Based on Truvestments Capital's 13F filing for Q4 2019, filed 29 Jan 2020.